Biaxial Mechanical Testing of Porcine Sclera Using Ultrasound Speckle Tracking for Strain Measurement

Author(s):  
Benjamin Cruz-Perez ◽  
Hugh J. Morris ◽  
Junhua Tang ◽  
Richard T. Hart ◽  
Xueliang Pan ◽  
...  

Glaucoma is a leading cause of blindness worldwide and is associated with characteristic optic nerve damage (Clark 2012). Intraocular pressure (IOP) induced deformation of the optic nerve head (ONH) and posterior sclera may be involved in the etiology of glaucomatous damage.

2021 ◽  
Author(s):  
Sophie Pilkinton ◽  
T.J. Hollingsworth ◽  
Brian Jerkins ◽  
Monica M. Jablonski

Glaucoma is a multifactorial, polygenetic disease with a shared outcome of loss of retinal ganglion cells and their axons, which ultimately results in blindness. The most common risk factor of this disease is elevated intraocular pressure (IOP), although many glaucoma patients have IOPs within the normal physiological range. Throughout disease progression, glial cells in the optic nerve head respond to glaucomatous changes, resulting in glial scar formation as a reaction to injury. This chapter overviews glaucoma as it affects humans and the quest to generate animal models of glaucoma so that we can better understand the pathophysiology of this disease and develop targeted therapies to slow or reverse glaucomatous damage. This chapter then reviews treatment modalities of glaucoma. Revealed herein is the lack of non-IOP-related modalities in the treatment of glaucoma. This finding supports the use of animal models in understanding the development of glaucoma pathophysiology and treatments.


1996 ◽  
Vol 6 (4) ◽  
pp. 415-420
Author(s):  
M. Adachi ◽  
K. Takahashi ◽  
K. Yuge ◽  
M. Nishikawa ◽  
H. Miki ◽  
...  

2017 ◽  
Vol 26 (12) ◽  
pp. 1095-1100 ◽  
Author(s):  
Alon Skaat ◽  
Stephanie Muylaert ◽  
Rachel S. Mogil ◽  
Rafael L. Furlanetto ◽  
Camila F. Netto ◽  
...  

Author(s):  
Armin Eilaghi ◽  
Ian A. Sigal ◽  
Christian G. Olesen ◽  
Inka Tertinegg ◽  
John G. Flanagan ◽  
...  

Glaucoma is a group of potentially blinding ocular diseases caused by gradual and progressive damage to the optic nerve, and is usually associated with elevated intraocular pressure (IOP) [1]. This damage occurs at the optic nerve head (ONH), the site where the optic nerve axons leave the posterior eye. IOP-related biomechanical factors are hypothesized to play a key role in the pathogenesis of glaucomatous damage [2].


2005 ◽  
Vol 64 (3) ◽  
Author(s):  
S.D. Mathebula

Glaucoma is a chronic or acute disease in which optic nerve damage occurs in a characteristic way. In  primary  open  angle  glaucoma  (POAG),  the manifestations of the optic nerve damage include visible excavation that develops in the optic nerve head and regions of the retina lose ability to detect all the elements that go into the total sensory prod-uct called vision.1, 2  When these regions worsen and enlarge to coalesce, the result is blindness.The intraocular pressure (IOP) has a causative role in producing the damage. All eyes have an in-ternal pressure to keep them inflated, perhaps 17 mmHg on the average, ± 5 mmHg standard devia-tion. In at least two thirds of the eyes that suffer glaucomatous damage, the intraocular pressure is high, at least a bit above the pressure found in 95% of the non-glaucomatous population. The cut-off is in the region of 20 to 22 mmHg used by most definitions.2 However, a normal or even low intra-ocular pressure can be harmful to some eyes, and when it is, the person has normal or low tension glaucoma. The traditional treatment of glaucoma has logically been to lower the intraocular pres-sure, to prevent further damage to the optic nerve, though previous damage is not undone.


2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Shu-Xian Fan ◽  
Peng Zeng ◽  
Zi-Jing Li ◽  
Jing Wang ◽  
Jia-Qi Liang ◽  
...  

Background. To investigate the clinical characteristics of Graves’ orbitopathy (GO) with elevated intraocular pressure (IOP) using the European Group of Graves’ Orbitopathy (EUGOGO) system. Methods. In this retrospective study, the clinical data of GO patients with elevated IOP (≥21 mmHg) were collected in Sun Yat-sen Memorial Hospital from January 2010 to June 2016. The demographic characteristics, clinical history of thyroid disease and GO, and ocular examination data were evaluated, and the activity and severity of GO were classified. Results. Data were collected from 58 eyes of 39 patients. The durations of thyroid disease and GO were 15.9 ± 18.9 months and 7.5 ± 6.2 months, respectively. The average IOP was 24.8 ± 5.3 mmHg (range: 21–55 mmHg). No significant difference in IOP was observed between active and inactive eyes. Eight eyes (13.8%), 29 eyes (50.0%), and 21 eyes (36.2%) were graded as mild, moderate-severe, and sight-threatening disease, respectively, according to the EUGOGO classification. The IOP was not significantly different among the three EUGOGO grades. No glaucomatous optic nerve damage or visual field defects were found. Conclusion. Increased IOP was evident for every grade of GO severity and activity of the EUGOGO system. IOP, glaucomatous optic nerve damage, and visual fields must be evaluated regularly during follow-up evaluations, regardless of the degree of activity and severity of GO.


Ophthalmology ◽  
1990 ◽  
Vol 97 (1) ◽  
pp. 9-17 ◽  
Author(s):  
Alfredo A. Sadun ◽  
Carl J. Bassi

2018 ◽  
Vol 59 (8) ◽  
pp. 3488 ◽  
Author(s):  
Naoki Kiyota ◽  
Yukihiro Shiga ◽  
Kohei Ichinohasama ◽  
Masayuki Yasuda ◽  
Naoko Aizawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document